P. Zingmark

Pharmacokinetic/pharmacodynamic models for the depletion of Vbeta5.2/5.3 T cells by the monoclonal antibody ATM-027 in patients with multiple sclerosis, as measured by FACS.

Mats O Karlsson, M. Karlsson, C. Edenius, 2004, British journal of clinical pharmacology.

Modeling Disease Progression in Acute Stroke Using Clinical Assessment Scales

F. Jonsson, M. Karlsson, K. Karlsson, 2010, The AAPS Journal.

Population pharmacokinetics of clomethiazole and its effect on the natural course of sedation in acute stroke patients.

Mats O Karlsson, E Niclas Jonsson, M. Karlsson, 2003, British journal of clinical pharmacology.

Treatment of acute ischaemic stroke with the low-affinity, use-dependent NMDA antagonist AR-R15896AR

H. Diener, W. Hacke, H. Basun, 2002, Journal of Neurology.

True nasopharyngeal absorption of zolmitriptan after administration via nasal spray in healthy male volunteers

M. Kågedal, R. Yates, P. Zingmark, 2005 .

Comparison of proportional and differential odds models for mixed-effects analysis of categorical data

Mats O. Karlsson, Maria C. Kjellsson, E. Niclas Jonsson, 2008, Journal of Pharmacokinetics and Pharmacodynamics.

Modelling a Spontaneously Reported Side Effect by Use of a Markov Mixed-Effects Model

Matts Kågedal, Mats O Karlsson, M. Karlsson, 2005, Journal of Pharmacokinetics and Pharmacodynamics.